Mr. Clark has more than 30 years of biopharmaceutical experience. He is currently the Co-founder and CEO of Vibrant Biomedicines, a venture-backed developer of vaccines targeted bacterial pathogens. Prior to joining Vibrant Biomedicines, Mr. Clark served as Chief Executive Officer of Nasdaq-listed biopharmaceutical company, Genocea Biosciences, Inc.. Prior to joining Genocea, Mr. Clark was Chief Business Officer at Vanda Pharmaceuticals Inc., a company he co-founded in 2004. Previously, he was a Principal at Care Capital, LLC, a venture capital firm investing in biopharmaceutical companies. Earlier in his career, he spent 10 years at SmithKline Beecham Corporation (now part of GlaxoSmithKline plc) in a variety of business development roles. Mr. Clark holds an MBA from The Wharton School at the University of Pennsylvania and a BA from Harvard University.
Team